This course is FREE with Unlimited CE!

Choose from two Unlimited CE subscription options and get access to 1000+ CE and professional development courses.

Goals and Learning Outcomes

Medically fragile babies require specialized care. Advancements in technology and improved interventions have reduced the adverse developmental sequelae that NICU graduates often face, but many will still be diagnosed with disabilities. Some will have disabilities severe enough to prevent them from functioning independently. Parents of these infants often experience high stress levels and trauma which can affect their ability to perform parental role functions and may impair bonding within the parent-infant dyad. Impaired bonding disrupts neonatal neurodevelopment and optimal psychosocial functioning. This module describes common needs and stressors that the parents of an infant in the neonatal intensive care unit (NICU) may experience, and reviews some of the adverse effects of parental stress. You will learn interventions to improve parental coping skills so you can provide developmentally supportive care for NICU infants by reducing parental stress.

The goal of this course is to educate nurses and social workers about family-centered interventions for families with infants in the NICU, focusing on up-to-date stress management and coping interventions in evidence-based neonatal practice. 


After taking this course, you should be able to:

  • Describe the common needs and stressors of parents with an infant in the NICU
  • Discuss parental stress and its relationship to infant and family health
  • Explain interventions for parental stress and coping and how to use them in practice
  • Recall interventions for parental stress and coping and how to use them in practice.
  • Identify the common stressors of parents with an infant in the NICU and the relationship between parental stress and infant health.

Course Termination Date: Not yet determined

Content Expiration Date: 12/31/25

Course Originally Released On: 03/01/22

Course Authors

4.5 Average

Course Reviews

10701 reviews

Accreditation Information

NURSES

In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Provider approved by the California Board of Registered Nursing, CEP#13791

Disclaimer: Not all courses will provide California Board of Registered Nursing approval. Per California Assembly Bill No. 241, continuing education courses related to direct patient care shall address at least one or a combination of the following:(1) Examples of how implicit bias affects perceptions and treatment decisions of licensees, leading to disparities in health outcomes; or (2) Strategies to address how unintended biases in decision-making may contribute to health care disparities by shaping behavior and producing differences in medical treatment along lines of race, ethnicity, gender identity, sexual orientation, age, socioeconomic status, or other characteristics.

 

CEBroker

Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, Kansas State Board of Nursing, Kentucky Board of Nursing, Michigan Board of Nursing, Mississippi Board of Nursing, New Hampshire Board of Nursing, New Mexico Board Of Nursing, North Dakota Board of Nursing, South Carolina Board Of Nursing and West Virginia Board Of Registered Nurses

 

Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.

 

Disclosures

None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.